INSTITUTION'S PROFILE
Janssen Vaccines and Prevention, Leiden, the Netherlands.
Publications (1)
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.
Journal: Nature communications
Publication date: 2024
Journal: Nature communications
Publication Year: 2024